Cargando…
Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper
Levosimendan is an inodilator that promotes cardiac contractility primarily through calcium sensitization of cardiac troponin C and vasodilatation via opening of adenosine triphosphate–sensitive potassium (K(ATP)) channels in vascular smooth muscle cells; the drug also exerts organ-protective effect...
Autores principales: | Herpain, Antoine, Bouchez, Stefaan, Girardis, Massimo, Guarracino, Fabio, Knotzer, Johann, Levy, Bruno, Liebregts, Tobias, Pollesello, Piero, Ricksten, Sven-Erik, Riha, Hynek, Rudiger, Alain, Sangalli, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319595/ https://www.ncbi.nlm.nih.gov/pubmed/30489437 http://dx.doi.org/10.1097/FJC.0000000000000636 |
Ejemplares similares
-
Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
por: Guarracino, Fabio, et al.
Publicado: (2018) -
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020) -
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020) -
Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safety
por: Girardis, M., et al.
Publicado: (2022) -
Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper
por: Cholley, Bernard, et al.
Publicado: (2019)